立体性身体放射疗法:一种新的非侵入性方法来进行肺动脉变皮
Manzhen Liao1,2, Taoyue Yao3, Yonghui Xie4
1Academy of Pediatrics, University of South China, Changsha, Hunan, China.
Frontiers in medicine
|July 10, 2025
概括
立体体辐射疗法 (SBRT) 为肺动脉高血压中肺动脉缩 (PADN) 提供了一种新的非侵入性方法. 这项研究证明了SBRT.
科学领域:
- 心脏病学 心脏病学
- 放射学 放射学是指放射学
- 肺部病理学 肺部病理学
背景情况:
- 肺动脉高血压 (PAH) 是一种严重的疾病,其特征是肺血管抵抗力增加.
- 导管式肺动脉缩 (PADN) 是一种现有的治疗方法,但需要非侵入性的替代方案.
- 对于PADN的立体体辐射疗法 (SBRT) 的疗效以前没有研究过.
研究的目的:
- 调查SBRT作为PADN的非侵入性方法的可行性和短期影响.
- 评估SBRT诱导的PADN对肺动力学和肺动脉结构在急性血栓栓塞性肺动脉高血压 (ATEPAH) 的子模型中的影响.
主要方法:
- 建立了一个ATEPAH的子模型.
- 子被随机分配到对照组或SBRT组 (15Grey单剂量).
- 在治疗后评估了血液动力学,右心室功能和肺动脉交感神经.
主要成果:
- SBRT成功诱导了PADN,降低了ATEPAH子的肺动脉缩和平均压力.
- SBRT-PADN减弱了肺动脉扩张,并对交感神经造成了结构性损伤.
- 没有观察到任何不良事件,肺动脉结构保存长达90天.
结论:
- SBRT显示出作为一种新的,非侵入性的PADN技术的潜力.
- 这项研究提供了SBRT-PADN.短期有效性和安全性的证据.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
227
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
227
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
263
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
263
Radiological Investigation III: Pulmonary Angiogram and PET Scan
171
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
171


